References
- Iadonato SP, Katze MG. Genomics: hepatitis C virus gets personal. Nature461, 357–358 (2009).
- Neumann UP, Berg T, Bahra M et al. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up. Transplantation77, 226–231 (2004).
- Schmidt SC, Bahra M, Bayraktar S et al. Antiviral treatment of patients with recurrent hepatitis C after liver transplantation with pegylated interferon. Dig. Dis. Sci.55, 2063–2069 (2010).
- Suppiah V, Moldovan M, Ahlenstiel G et al. IL28b is associated with response to chronic hepatitis C interferon-α and ribavirin therapy. Nat. Genet.41, 1100–1104 (2009).
- Tanaka Y, Nishida N, Sugiyama M et al. Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C. Nat. Genet.41, 1105–1109 (2009).
- Falleti E, Fabris C, Toniutto P et al. Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C. J. Interferon Cytokine Res.27, 239–246 (2007).
- Toniutto P, Fabris C, Falleti E et al. Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C. Liver Int.28, 257–263 (2008).
- Fabris C, Toniutto P, Bitetto D et al. Low fibrosis progression of recurrent hepatitis C in apolipoprotein E ε4 carriers: relationship with the blood lipid profile. Liver Int.25, 1128–1135 (2005).
- Ben-Ari Z, Pappo O, Druzd T et al. Role of cytokine gene polymorphism and hepatic transforming growth factor β1 expression in recurrent hepatitis C after liver transplantation. Cytokine27, 7–14 (2007).
- Ben-Ari Z, Tambur AR, Pappo O et al. Platelet-derived growth factor gene polymorphism in recurrent hepatitis C infection after liver transplantation. Transplantation81, 392–397 (2006).
- Dhillon N, Walsh L, Kruger B et al. A single nucleotide polymorphism of Toll-like receptor 4 identifies the risk of developing graft failure after liver transplantation. J. Hepatol.53, 67–72 (2010).
- Charlton MR, Thompson A, Veldt BJ et al. Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection. Hepatology53, 317–324 (2011).
- Eurich D, Boas-Knoop S, Ruehl M et al. Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation. Liver Transplant.17, 289–298 (2011).
- Manolio TA. Genomewide association studies and assessment of the risk of disease. N. Engl. J. Med.363, 166–176 (2010).
- Rauch A, Kutalik Z, Descombes P et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology138, 1338–1345 (2010).